Showing results (111-120 of 162) with videos related to
Sort By:
Pageof 17
Journal of Hepatology|January 18, 2019
Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of careTimothy Papaluca, Lucy McDonald, Anne Craigie, et al.Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.Nature Communications|April 7, 2023
No carbon storage in growth-limited trees in a semi-arid woodlandR Alexander Thompson, Henry D Adams, David D Breshears, et al.Haematologica|March 30, 2013
HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapyGlenda J Dickson, Fabio G Liberante, Laura M Kettyle, et al.BMC Bioinformatics|May 8, 2012
Metaprotein expression modeling for label-free quantitative proteomicsJoseph E Lucas, J Will Thompson, Laura G Dubois, et al.Blood|June 20, 2013
RNAi screen identifies Jarid1b as a major regulator of mouse HSC activitySonia Cellot, Kristin J Hope, Jalila Chagraoui, et al.Vox Sanguinis|February 6, 2020
Blood donation amongst people who inject drugs in Australia: research supporting policy changeBrendan Quinn, Ruth Pearson, Julia Cutts, et al.Journal of Gastroenterology and Hepatology|November 7, 2019
Increasing prevalence of primary biliary cholangitis in Victoria, AustraliaJanine French, Ingrid van der Mei, Steve Simpson, et al.Emergency Medicine Journal : EMJ|April 17, 2023
External validation of the Manchester Acute Coronary Syndromes ECG risk model within a pre-hospital settingAhmed Alotaibi, Abdulrhman Alghamdi, Glen P Martin, et al.Antiviral Therapy|February 12, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studiesMarianne Martinello, Margaret Hellard, David Shaw, et al.Pageof 17